NDLTD Global ETD Search
  • Refine Query
  • Source
  • Publication year
  • to
  • Language
  • No language data
  • Tagged with
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.

Search results

Showing 1 to 3 of 3 (0.076 seconds)

Spelling suggestions: "subject:"generic prevalence"" "subject:"jeneric prevalence""

1

Prescribing patterns of angiotensin-converting enzyme inhibitors for the period 2001 until 2006 / Lourens Johannes Rothmann

Rothmann, Lourens Johannes January 2007 (has links)
Thesis (M.Pharm. (Pharmacy Practice))---North-West University, Potchefstroom Campus, 2008.
ACE inhibitors
Hypertension
Congestive heart failure
Cardiovascular diseases
Pharmacoeconomics
Drug utilisation review
Cost savings
Innovator
Generic prevalence
Active ingredient
Pricing regulations
2

Prescribing patterns of angiotensin-converting enzyme inhibitors for the period 2001 until 2006 / Lourens Johannes Rothmann

Rothmann, Lourens Johannes January 2007 (has links)
Thesis (M.Pharm. (Pharmacy Practice))---North-West University, Potchefstroom Campus, 2008.
ACE inhibitors
Hypertension
Congestive heart failure
Cardiovascular diseases
Pharmacoeconomics
Drug utilisation review
Cost savings
Innovator
Generic prevalence
Active ingredient
Pricing regulations
3

Prescribing patterns of angiotensin-converting enzyme inhibitors for the period 2001 until 2006 / Lourens Johannes Rothmann

Rothmann, Lourens Johannes January 2007 (has links)
Thesis (M.Pharm. (Pharmacy Practice))---North-West University, Potchefstroom Campus, 2008.
ACE inhibitors
Hypertension
Congestive heart failure
Cardiovascular diseases
Pharmacoeconomics
Drug utilisation review
Cost savings
Innovator
Generic prevalence
Active ingredient
Pricing regulations

Page generated in 0.0801 seconds